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Antimicrobial drugs can interact directly with the immune system of man and animal. A 
growing evidence can be found in literature that some antimicrobials exert their beneficial 
effects not only by killing or inhibiting the growth of bacterial pathogens but also indirectly 
by immunomodulation and by influencing the cytokine production. Aspects of the immune 
system which are reported to be influenced by chemotherapeutics and antibiotics are: 
phagocytosis, apoptosis, chemotaxis, lymphocyte proliferation, cytokine expression, antibody 
formation, hypersensitivity reaction, opsonisation, intracellular killing and PMN penetration. 
Several studies in different species were undertaken to quantify and compare the 
immunomodulatory properties of antimicrobial agents. It is remarkable from the reported 
results that statements hereby are very diverse and sometimes even controversial for a 
particular active substance or class of antibiotics. 
Concerning phagocytosis, positive effects were seen for cephalosporins, carbapenems, 
amphotericin B, florfenicol and clindamycin, while negative effects were rather observed for 
erythromycin, azithromycin, tetracycline, ampicillin and gentamicin. 
Lincomycin, clindamycin and imipenem induce chemotaxis, whereas rifampicin and 
cefotaxime should decrease this cell activity. Regarding lymfocyte proliferation, macrolides 
would have a strong stimulating effect while tetracyclines have a negative effect. 
Erythromycin, broad spectrum penicillins and amphotericin B appear to stimulate production 
of the anti-inflammatory types of cytokines. 
Reduction of IL-6 and a clear anti-inflammatory result of tobramycin and ceftazidime could 
be demonstrated in pigs with endotoxin shock. Endotoxin neutralization has been reported for 
polymyxin E in the same animal species. 
The anti-inflammatory properties of macrolides and triamilides in chronic inflammatory 
pulmonary disease were several times documented. These group of antimicrobial substances 
should also establish an adjunctive treatment to β-lactams by their immunomodulatory 
properties in man. 
Bactericidal antibiotics such as rifampicin, clindamycin and aminoglycosides kill pathogens 
and prevent at the same time that high quantities of pro-inflammatory cell wall components 
are released. 
It has been shown that fluoroquinolones can induce growth factor IL-2 synthesis in vitro and 
at the same time hamper the secretion of pro-inflammatory IL-1β and TNF-α. This potential 
of immunomodulatory effects of these broad-spectrum antibacterial chemotherapeutics could 
be of great interest in patients confronted with immunosuppression and chronic inflammatory 
diseases. 
For most antimicrobial agents, however, the number of studies reported seems at the moment 
to be too scarce to be conclusive for an ultimate interpretation of their effects on cytokine 
production. 
Also the direct immunomodulation effect of antimicrobial agents should be interpreted 
carefully with regard to possible therapeutic implication. 
